Journal article Open Access
Ayoubi, Riham;
McPherson, Peter S.;
Laflamme, Carl
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd"> <identifier identifierType="DOI">10.5281/zenodo.4733123</identifier> <creators> <creator> <creatorName>Ayoubi, Riham</creatorName> <givenName>Riham</givenName> <familyName>Ayoubi</familyName> <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-6633-655X</nameIdentifier> <affiliation>Montreal Neurological Institute</affiliation> </creator> <creator> <creatorName>McPherson, Peter S.</creatorName> <givenName>Peter S.</givenName> <familyName>McPherson</familyName> <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-7806-5662</nameIdentifier> <affiliation>Montreal Neurological Institute</affiliation> </creator> <creator> <creatorName>Laflamme, Carl</creatorName> <givenName>Carl</givenName> <familyName>Laflamme</familyName> <nameIdentifier nameIdentifierScheme="ORCID" schemeURI="http://orcid.org/">0000-0001-5906-025X</nameIdentifier> <affiliation>Montreal Neurological Institute</affiliation> </creator> </creators> <titles> <title>Antibody Characterization Report for Solute carrier family 2, facilitated glucose transporter member 6 SLC2A6 (GLUT-6)</title> </titles> <publisher>Zenodo</publisher> <publicationYear>2021</publicationYear> <subjects> <subject>Solute carrier family 2, facilitated glucose transporter member 6</subject> <subject>Glucose transporter type 6</subject> <subject>GLUT-6</subject> <subject>SLC2A6</subject> <subject>Q9UGQ3</subject> <subject>antibody characterization</subject> <subject>antibody validation</subject> </subjects> <dates> <date dateType="Issued">2021-05-02</date> </dates> <language>en</language> <resourceType resourceTypeGeneral="JournalArticle"/> <alternateIdentifiers> <alternateIdentifier alternateIdentifierType="url">https://zenodo.org/record/4733123</alternateIdentifier> </alternateIdentifiers> <relatedIdentifiers> <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.4733122</relatedIdentifier> <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/openlabnotebooks</relatedIdentifier> <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/resolute</relatedIdentifier> <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/sgc-opennotebook</relatedIdentifier> <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/ycharos</relatedIdentifier> </relatedIdentifiers> <rightsList> <rights rightsURI="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International</rights> <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights> </rightsList> <descriptions> <description descriptionType="Abstract"><p>Head to head comparison of available commercial antibodies against Solute carrier family 2, facilitated glucose transporter member 6&nbsp;<strong>SLC2A6 </strong>(GLUT-6) by immunoblot (Western blot).&nbsp;Work performed in collaboration with the RESOLUTE consortium (<a href="http://re-solute.eu/">re-solute.eu</a>). RESOLUTE received support from the EU/EFPIA Innovative Medicines Initiative 2 Joint Undertaking (RESOLUTE grant No 777372).</p></description> </descriptions> </resource>
All versions | This version | |
---|---|---|
Views | 172 | 172 |
Downloads | 120 | 120 |
Data volume | 68.9 MB | 68.9 MB |
Unique views | 162 | 162 |
Unique downloads | 115 | 115 |